India's top court to rule on survival of revocation pleas for expired patents
By Freny Patel ( May 13, 2026, 05:05 GMT | Comment) -- India’s top court will decide whether patent revocation proceedings survive patent expiry, in Boehringer’s Linagliptin dispute with Macleods. The Supreme Court of India's ruling is expected to reshape pharmaceutical litigation, patent enforcement and India’s intellectual property jurisprudence.India's top court is set to decide a significant legal paradox on the survival of revocation proceedings against a patent after its expiry....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.